{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:53:37Z","timestamp":1790268817390,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874263"],"award-info":[{"award-number":["81874263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is now recognized as the most prevalent hepatic disorder worldwide, and an unhealthy lifestyle is the leading risk factor for its occurrence. Vitamin C (VC) has been suggested to protect NAFLD, whereas evidence from randomized controlled trials (RCTs) is sparse. In this study, we aimed to investigate the potential benefits of VC supplementation daily on liver health and associated parameters in patients with NAFLD. In this double-blind, RCT, 84 patients with NAFLD, aged 18\u201360 years old, were assigned to 12 weeks of oral treatment with either low (250 mg\/day, <jats:italic>n<\/jats:italic> = 26), medium (1,000 mg\/day, <jats:italic>n<\/jats:italic> = 30), or high (2,000 mg\/day, <jats:italic>n<\/jats:italic> = 28) doses of VC supplements. After the intervention, the Medium group had a more significant decrease in aspartate aminotransferase [Medium, \u22125.00 (\u221210.25, \u22121.75) vs. High, \u22122.50 (\u22127.75, 0.00), <jats:italic>P<\/jats:italic> = 0.02] and alanine aminotransferase [Medium, \u22128.00 (\u221218.00, \u22121.75) vs. High, \u22123.50 (\u221213.75, 4.25), <jats:italic>P<\/jats:italic> = 0.05; Medium vs. Low, \u22123.00 (\u22129.00, 5.50), <jats:italic>P<\/jats:italic> = 0.031]. The levels of other indicators of liver health, such as gamma-glutamyl transferase, alkaline phosphatase, total bilirubin, and direct bilirubin were decreased after the intervention but comparable among the three groups and so did the parameters of glucose metabolism, such as fasting insulin, fasting glucose, and homeostasis model assessment for insulin resistance. The plasma level of VC in patients and total adiponectin and high molecular weight (HMW) adiponectin levels were also elevated but not in a dose-dependent manner. Meanwhile, analysis of fecal microbiota composition showed an increase in the alpha diversity (Abundance-based Coverage Estimator (ACE), Shannon, chao1, and Simpson) both in the Low and the Medium groups. A total of 12 weeks of VC supplementation, especially 1,000 mg\/day, improved liver health and glucose metabolism in patients with NAFLD. The elevated plasma levels of VC, total and HMW adiponectin, and the improvement of intestinal microbiota may have made some contributions.<\/jats:p>","DOI":"10.3389\/fnut.2021.745609","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T04:49:06Z","timestamp":1631594946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial"],"prefix":"10.3389","volume":"8","author":[{"given":"Zhangya","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangrui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD From 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1089\/dia.2020.2513","article-title":"NAFLD\/NASH and diabetes","volume":"22","author":"Garg","year":"2020","journal-title":"Diabetes Technol Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J Clin Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/nu12092762","article-title":"New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress","volume":"12","author":"Ferro","year":"2020","journal-title":"Nutrients."},{"key":"B7","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J Gastroentero."},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/07315724.2003.10719272","article-title":"Vitamin C as an antioxidant: evaluation of its role in disease prevention","volume":"22","author":"Padayatty","year":"2003","journal-title":"J Am Coll Nutr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10715762.2012.734916","article-title":"Protective roles of ascorbic acid in oxidative stress induced by depletion of superoxide dismutase in vertebrate cells","volume":"47","author":"Tamari","year":"2013","journal-title":"Free Radical Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0147985","DOI":"10.1371\/journal.pone.0147985","article-title":"Association between dietary vitamin C intake and non-alcoholic fatty liver disease: a cross-sectional study among middle-aged and older adults","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS ONE."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/jgh.12520","article-title":"Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults","volume":"29","author":"Han","year":"2014","journal-title":"J Gastroen Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jand.2014.01.009","article-title":"A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls","volume":"114","author":"Da Silva","year":"2014","journal-title":"J Acad Nutr Diet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0139310","DOI":"10.1371\/journal.pone.0139310","article-title":"Diet-Quality scores and prevalence of nonalcoholic fatty liver disease: a population study using proton-magnetic resonance spectroscopy","volume":"10","author":"Chan","year":"2015","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/S0735-1097(00)00616-1","article-title":"Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species","volume":"35","author":"Hirashima","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nut.2014.05.011","article-title":"Effects of total vitamin A, vitamin C, and fruit intake on risk for metabolic syndrome in Korean women and men","volume":"31","author":"Park","year":"2015","journal-title":"Nutrition."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0163571","DOI":"10.1371\/journal.pone.0163571","article-title":"Dietary vitamin C intake reduces the risk of type 2 diabetes in Chinese adults: HOMA-IR and T-AOC as potential mediators","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"105665","DOI":"10.1016\/j.phrs.2021.105665","article-title":"Does vitamin C supplementation exert profitable effects on serum lipid profile in patients with type 2 diabetes? A systematic review and dose-response meta-analysis","volume":"169","author":"Namkhah","year":"2021","journal-title":"Pharmacol Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/nu10070895","article-title":"SunGold kiwifruit supplementation of individuals with prediabetes alters gut microbiota and improves vitamin c status, anthropometric and clinical markers","volume":"10","author":"Wilson","year":"2018","journal-title":"Nutrients."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/ejcn.2017.24","article-title":"Effects of vitamin C supplementation on glycaemic control: a systematic review and meta-analysis of randomised controlled trials","volume":"71","author":"Ashor","year":"2017","journal-title":"Eur J Clin Nutr."},{"key":"B21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin\u2013journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"592404","DOI":"10.5402\/2011\/592404","article-title":"Obesity, visceral fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease","volume":"2011","author":"Mirza","year":"2011","journal-title":"ISRN Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3748\/wjg.v19.i6.802","article-title":"What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?","volume":"19","author":"Finelli","year":"2013","journal-title":"World J Gastroentero."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.3892\/mmr.2019.10457","article-title":"Ascorbic acid attenuates cell stress by activating the fibroblast growth factor 21\/fibroblast growth factor receptor 2\/adiponectin pathway in HepG2 cells","volume":"20","author":"Gu","year":"2019","journal-title":"Mol Med Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/j.1463-1326.2010.01297.x","article-title":"Synergistic effects of ascorbic acid and thiazolidinedione on secretion of high molecular weight adiponectin from human adipocytes","volume":"12","author":"Rose","year":"2010","journal-title":"Diabetes Obes Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.metabol.2017.03.013","article-title":"Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota","volume":"71","author":"Doulberis","year":"2017","journal-title":"Metabolism."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"Embo Mol Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/1753-0407.12056","article-title":"Study Group of Liver and Metabolism Chinese Society of Endocrinology. Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the study group of liver and metabolism, Chinese society of endocrinology","volume":"5","author":"Gao","year":"2013","journal-title":"J Diabetes."},{"key":"B31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1631\/jzus.B1600341","article-title":"Dietary guidelines for Chinese residents (2016): comments and comparisons","volume":"17","author":"Wang","year":"2016","journal-title":"J Zhejiang Univ Sci B."},{"key":"B32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00217-006-0269-1","article-title":"Determination of ascorbic and dehydroascorbic acid in lean and fatty fish species by high-performance liquid chromatography with fluorometric detection","volume":"223","author":"Iglesias","year":"2006","journal-title":"Eur Food Res Technol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.gtc.2019.09.003","article-title":"Nutrition and nonalcoholic fatty liver disease: current perspectives","volume":"49","author":"Chakravarthy","year":"2020","journal-title":"Gastroenterol Clin North Am."},{"key":"B34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-Gomez","year":"2017","journal-title":"J Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia."},{"key":"B37","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA."},{"key":"B38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MCC.0000000000000622","article-title":"Safety of vitamin C in sepsis: a neglected topic","volume":"25","author":"Khoshnam-Rad","year":"2019","journal-title":"Curr Opin Crit Care."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1139\/cjpp-2016-0561","article-title":"The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells","volume":"95","author":"Izdebska","year":"2017","journal-title":"Can J Physiol Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.dld.2019.06.005","article-title":"Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease","volume":"51","author":"Ivancovsky-Wajcman","year":"2019","journal-title":"Digest Liver Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.bbagen.2014.03.019","article-title":"Ascorbic acid deficiency affects genes for oxidation-reduction and lipid metabolism in livers from SMP30\/GNL knockout mice","volume":"1840","author":"Takahashi","year":"2014","journal-title":"Bba-Gen Subjects."},{"key":"B42","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.biopha.2020.110792","article-title":"Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice","volume":"131","author":"Zeng","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.3390\/nu6125473","article-title":"Does vitamin C deficiency promote fatty liver disease development?","volume":"6","author":"Ipsen","year":"2014","journal-title":"Nutrients."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J Hepatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2016.40.1.1","article-title":"Novel molecular mechanisms in the development of non-alcoholic steatohepatitis","volume":"40","author":"Povero","year":"2016","journal-title":"Diabetes Metab J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"dgaa382","DOI":"10.1210\/clinem\/dgaa382","article-title":"Effect of gut microbiota and PNPLA3 rs738409 variant on nonalcoholic fatty liver disease (NAFLD) in obese youth","volume":"105","author":"Monga Kravetz","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12938\/bmfh.2020-046","article-title":"Correlation of gut firmicutes\/bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease","volume":"40","author":"Jasirwan","year":"2021","journal-title":"Biosci Microbiota Food Health."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.745609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T04:49:09Z","timestamp":1631594949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.745609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":52,"alternative-id":["10.3389\/fnut.2021.745609"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2021.745609","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"article-number":"745609"}}